Attention NASDAQ:AVEO Investors: Lawsuit Against AVEO Pharmaceuticals, Inc. Filed
An investor in shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged securities laws violations by AVEO Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between January 3, 2012 and May 1, 2013 concerning its drug Tivopath or tivozanib.
View full press release